<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996381</url>
  </required_header>
  <id_info>
    <org_study_id>YonseiU</org_study_id>
    <nct_id>NCT04996381</nct_id>
  </id_info>
  <brief_title>Prediction of Left Ventricular Ejection Fraction Using Artificial Intelligence by Chest Radiography</brief_title>
  <acronym>AI-CXR</acronym>
  <official_title>Prediction of Left Ventricular Ejection Fraction Using Artificial Intelligence by Chest Radiography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will develop an artificial intelligence model to predict left ventricular&#xD;
      ejection fraction using chest radiographic images and transthoracic echocardiography data.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Echocardiography should be considered at an early stage in patients who have first developed&#xD;
      heart failure or who do not have information about heart function, but the examination may be&#xD;
      delayed due to lack of time and manpower in the actual medical field.&#xD;
&#xD;
      Primary Objective: Use chest radiographs to predict the left ventricular ejection fraction&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2021</start_date>
  <completion_date type="Anticipated">October 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Left Ventricular Ejection Fraction &lt; 40%</measure>
    <time_frame>Within two weeks of chest X-ray</time_frame>
    <description>Evaluate the performance of chest X-ray based artificial intelligence algorithms to identify individuals with reduced ejection fraction (&lt;40%)</description>
  </primary_outcome>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Chest X-ray for Clinical Evaluation</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Scanning Chest X-rays and performing AI algorithms on images</intervention_name>
    <description>Chest X-Rays; AI CNNs; Results</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing a transthoracic echocardiogram will be enrolled.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adults who are 18 years and older&#xD;
&#xD;
          -  Complete a transthoracic echocardiogram within 14 days before or after chest X-ray&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal&#xD;
&#xD;
          -  Uncertain radiographs&#xD;
&#xD;
          -  Uncertain tests results&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>In Hyun Jung, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Yongin Severance Hospital, Yonsei University College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Yongin Severance Hospital</name>
      <address>
        <city>Yongin</city>
        <state>Giheung-gu</state>
        <zip>16995</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 4, 2021</study_first_submitted>
  <study_first_submitted_qc>August 4, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>August 7, 2021</last_update_submitted>
  <last_update_submitted_qc>August 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yonsei University</investigator_affiliation>
    <investigator_full_name>SungA Bae</investigator_full_name>
    <investigator_title>MD. PhD.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

